Literature DB >> 20724903

Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma.

Prakash Chandra1, Shadi Sadeghi Yarandi, Natasha Khazai, Sol Jacobs, Guillermo E Umpierrez.   

Abstract

Metastatic insulinomas may present with recurrent life-threatening hypoglycemia. Treatment of hypoglycemia in such patients is difficult and frequently fails to respond to numerous therapeutic agents, requiring continuous dextrose infusion. The authors present our experience with Yttirum-90 radioembolization in a patient with metastatic malignant insulinoma who failed to respond to distal pancreatectomy, systemic chemotherapy with capecitabine and everolimus and medical treatment with somatostatin analogues, diazoxide and corticosteroids. Treatment with repeated Y-90 radioembolization resulted in rapid resolution of hypoglycemic events, allowing discontinuation of dextrose infusion and hospital discharge. However, the effect of Y-90 administration seems to be transient and without evidence of tumor shrinkage in imaging studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724903     DOI: 10.1097/MAJ.0b013e3181ee7be2

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

Review 2.  Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  J Gastroenterol       Date:  2012-08-11       Impact factor: 7.527

3.  Management of malignant insulinoma.

Authors:  J C Ferrer-García; V Iranzo González-Cruz; S Navas-DeSolís; M Civera-Andrés; C Morillas-Ariño; A Merchante-Alfaro; C Caballero-Díaz; C Sánchez-Juan; C Camps Herrero
Journal:  Clin Transl Oncol       Date:  2013-03-05       Impact factor: 3.405

4.  Pancreatic endocrine tumors.

Authors:  Ake Andrén-Sandberg
Journal:  N Am J Med Sci       Date:  2011-04

5.  A case of inoperable malignant insulinoma with resistant hypoglycemia who experienced the most significant clinical improvement with everolimus.

Authors:  Emre Bozkirli; Okan Bakiner; Huseyin Abali; Cagatay Andic; Ali Fuat Yapar; Fazilet Kayaselcuk; Eda Ertorer
Journal:  Case Rep Endocrinol       Date:  2013-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.